(Q42486064)

English

Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis

scientific article published on November 2005

Statements

Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis (English)
John C Mavropoulos
Miguel Cuchacovich
Carolina Llanos
Juan C Aguillón
Hector Gatica
Salvatore V Pizzo
Mario Gonzalez-Gronow
1 November 2005
2116-2124

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit